中文 | English
Return
Total: 147 , 1/15
Show Home Prev Next End page: GO
Author:(MA Xiaomei)

1.Research progress on application of lactoferrin in clinical field

MA Xiaomei

Chinese Journal of Biologicals 2024;37(2):245-250

2.IGF-1 and PKC expressions in left ventricular remodeling in rats after myocardial infarction

Xiaomei YUAN ; Kanghua MA

Journal of Third Military Medical University 2002;0(12):-

3.Application of flash 2D-animation in the pathology teaching

Xiaomei MA ; Huimin LIU

Chinese Journal of Medical Education Research 2005;0(06):-

4.Selection of the treatment strategies of myelodysplastic syndromes based on clone category

Xiaomei HU ; Junli MA

Journal of Leukemia & Lymphoma 2011;20(12):759-762

5.Treatment focused on myelodysplastic syndromes based on cytogenetic categories

Rou MA ; Xiaomei HU

Journal of Leukemia & Lymphoma 2010;19(5):262-264

6.Effect of olmesartan medoxomil on renal oxidative stress in mice with chronic heart failure

Xiaomei LU ; Ling MA ; Yanqiu YU

Chinese Journal of Nephrology 2011;27(3):190-193

7.Analysis and treatment of the complications caused by polyacrylamide hydrogel injection for augmentation rhinoplasty

Xinghui TANG ; Xiaomei LONG ; Xiao MA

Chinese Journal of Medical Aesthetics and Cosmetology 2009;15(6):381-383

8.Wnt3a induces rat bone marrow mesenchymal stem cells differentiation into neuron-like cells

Xiaomei WANG ; Changzheng MU ; Yunsheng MA

Chinese Journal of Tissue Engineering Research 2010;14(23):4363-4366

9.Analysis of curative effect of shenmai in treatment female patients with coronany heart disease

Xiaomei SUN ; Guangxian MA ; Guoling YAO

Chinese Journal of Primary Medicine and Pharmacy 2012;19(9):1306-1307

10.Netherton syndrome caused by serine protease inhibitor of Kazal type 5 gene mutation: a case report and literature review

Xiaomei HUO ; Xiaohui GONG ; Li MA

Chinese Journal of Perinatal Medicine 2021;24(1):54-60

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 147 , 1/15 Show Home Prev Next End page: GO